The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulations

Journal of Pharmaceutical Sciences

Volumn 100, Issue 5, 2011, Pages 1671-1678

  Mach, Henryk ^a   Bhambhani, Akhilesh ^a   Meyer, Brian K ^a   Burek, Steven ^a   Davis, Harrison ^a   Blue, Jeffrey T ^a   Evans, Robert K ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Analytical biochemistry; High throughput technologies; Imaging methods; Light scattering; Particle size; Protein aggregation; Protein formulation; Stability

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; DRUG FORMULATION; FLOW CYTOMETRY; FLUORESCENCE; PARTICLE SIZE; PROTEIN AGGREGATION;

EID: 79952218924     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22414     Document Type: Article

References (32)

1. Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G, Fan YX, Kirshner S, Verthelyi D, Kozlowski S, Clouse KA, Swann PG, Rosenberg A, Cherney B. 2009. Overlooking subvisible particles in therapeutic protein products: Gaps that may compromise product quality. J Pharm Sci 98(4):1201-1205.
2. Singh SK, Afonina N, Awwad M, Bechtold-Peters K, Blue JT, Chou D, Cromwell M, Krause HJ, Mahler HC, Meyer BK, Narhi L, Nesta DP, Spitznagel T. 2010. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. J Pharm Sci 99(8):3302-3321.
3. Das T, Nema S. 2008. Protein particulate issues in biologics development. Am Pharm Rev 11(4):52, 54-57.
4. Capelle MAH, Gurny R, Arvinte T. 2007. High throughput screening of protein formulation stability: Practical considerations. Eur J Pharm Biopharm 65(2):131-148.
5. Wyatt Technology Corporation. DynaProTM Plate Reader. Santa Barbara, CA. Accessed Dec 7, 2010 at.
6. Koppel DE. 1972. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: The method of cumulants. J Chem Phys 57(11):4814-4820.
7. Griffiths D, Hole P, Smith J, Carr B. 2009. Characterization of nanoparticle dispersions by size and scattering intensity simultaneously. Nanotech Conf Expo 1:414-416.
8. Filipe V, Hawe A, Jiskoot W. 2010. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27(5):796-810.
9. Narhi LO, Jiang Y, Cao S, Benedek K, Shnek D. 2009. A critical review of analytical methods for subvisible and visible particles. Curr Pharm Biotechnol 10:373-381.
10. Tyagi AK, Randolph TW, Dong A, Maloney KM, Hitscherich C Jr., Carpenter JF. 2009. IgG particle formation during filling pump operation: A case study of heterogeneous nucleation on stainless steel nanoparticles. J Pharm Sci 98(1):94-104.
11. Huang CT, Sharma D, Oma P, Krishnamurthy R. 2009. Quantitation of protein particles in parenteral solutions using micro-flow imaging. J Pharm Sci 98(9):3058-3071.
12. Wuchner K, Buechler J, Spycher R, Dalmonte P, Volkin DB. 2010. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation. J Pharm Sci 99(8):3343-3361.
13. Sharma DK, Oma P, Pollo MJ, Sukumar M. 2010. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging. J Pharm Sci 99:2628-2642.
14. Cytomics FC-500 FLow Cytometry System. Beckman-Coulter online documentation, DS-9812A., Accessed June 7, 2010, at.
15. Demeule B, Gurny R, Arvinte T. 2007. Detection and characterization of protein aggregates by fluorescence microscopy. Int J Pharm 329(1-2):37-45.
16. Jorio H, Tran R, Meghrous J, Bourget L, Kamen A. 2006. Analysis of baculovirus aggregates using flow cytometry. J Virol Methods 134(1-2):8-14.
17. Ginsberg MH, Frelinger AL, Lam SCT, Forsyth J, McMillan R, Plow EF, Shattil SJ. 1990. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. Blood 76(10):2017-2023.
18. Harding SA, Din JN, Sarma J, Jessop A, Weatherall M, Fox KAA, Newby DE. 2007. Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: Methodological considerations. Thromb Haemost 98(2):451-456.
19. Wall J, Solomon A. 1999. Flow cytometric characterization of amyloid fibrils. Methods Enzymol 309:460-466.
20. Lo MC, Aulabaugh A, Jin G, Cowling R, Bard J, Malamas M, Ellestad G. 2004. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem 332(1):153-159.
21. Mach H, Middaugh CR, Lewis RV. 1992. Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. Anal Biochem 200(1):74-80.
22. Mach H, Sanyal G, Volkin DB, Middaugh CR. 1997. Applications of ultraviolet absorption spectroscopy to the analysis of biopharmaceuticals. In Therapeutic protein and peptide formulation and delivery; Shahrokh Z, Sluzky V, Cleland JL, Shire SJ, Randolph TW, Eds. Washington, District of Columbia: American Chemical Society Symposium Series 675:186-205.
23. Mahler HC, Friess W, Grauschopf U, Kiese S. 2009. Protein aggregation: Pathways, induction factors and analysis. J Pharm Sci 98(9):2909-2934.
24. Etzler F, Sanderson M. 1995. Particle size analysis: A comparative study of various methods. Part Part Syst Charact 12:217-224.
25. Hawe A, Friess W. 2007. Stabilization of a hydrophobic recombinant cytokine by human serum albumin. J Pharm Sci 96:2987-2999.
26. Mie G. 1908. Contributions to the optics of turbid media, especially colloidal metal solutions. Ann Phys 25:377-445.
27. Cromwell MEM, Carpenter JF, Scherer T, Randolph TW. 2008. Opalescence in antibody formulations is a solution critical phenomenon. In Abstracts of papers, 236th ACS National Meeting, Philadelphia, Pennsylvania: BIOT-029.
28. Demeule B, Palais C, Machaidze G, Gurny R, Arvinte T. 2009. New methods allowing the detection of protein aggregates: A case study on trastuzumab. MAbs 1(2):142-150.
29. Hawe A, Friess W, Sutter M, Jiskoot W. 2008. Online fluorescent dye detection method for the characterization of immunoglobulin G aggregation by size exclusion chromatography and asymmetrical flow field flow fractionation. Anal Biochem 378(2):115-122.
30. Hawe A, Sutter M, Jiskoot W. 2008. Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res 25(7):1487-1499.
31. Steinberg TH, Haugland RP, Singer VL. 1996. Application of SYPRO orange and SYPRO red protein gel stains. Anal Biochem 239(2):238-245.
32. 2010. Proteostat™ thermal shift stability assay. Publication ENZ-51027-K400. PLymouth Meeting, Pennsylvania: Enzo Life Sciences.